Mon, Jul 14, 2014, 1:16 AM EDT - U.S. Markets open in 8 hrs 14 mins

Recent

% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

fizrwinnr11 304 posts  |  Last Activity: Apr 11, 2014 1:25 PM Member since: Jan 7, 2011
  • fizrwinnr11 fizrwinnr11 Apr 11, 2014 1:25 PM Flag

    GAP Stores, which has a December fiscal year, reported miserable results for their March quarter. A major reason for that had to be the massive ice storms in the month of January.

    My guess is that a large fund seeing the Gap results and seeing JCP unable to break $9 on a closing basis decided to bail. But the major thing being forgotten here is that JCP has a January fiscal year and they have ALREADY reported results which include the month of January. JCP's Q1 will NOT be negatively impacted by those ice storms at all and anyone concluding that Gap's results is what most retailers will report in Q1 is just plain wrong,. The "brilliant" funds strike again.

  • The stock was at $8.71 shortly after announcing that October same-store comps were positive for the first time in almost two years. Then pre-market the next day, management gave its forecast for the holiday quarter. On that piece of news, the stock surged to $9.44 and was to top ten bucks before the month was out.

    That, mind you, was BEFORE they announced the positive revenue surprise for the month of November.
    So if the stock was in the $9 area after management gave its holiday quarter guidance, why logically should it be just $6.52 guidance after those earnings were recently reiterated and when the comp;any is closing 33 of its worst-performing stores which will save $65M a year (22 cents a share)?

    The only reason is the steady drumbeat of negative blogs by the bears and shorts. How many negative blogs is Motley Fool going to put out each days with headlines such as "Is the End Near for JCP Penney," etc.
    The recovery is coming along nicely as one might expect when $2B in cash is thrown at the problem - but you would never know it by reading the sensationalistic headlines and negativity out of the likes of Motley Fool.

    But all of the innuendoes and outright lies will come to a screeching halt once the audited financial statements come out next month and management gives guidance for the upcoming quarter and fiscal year. In the short term, perception is reality but it is reality that will be dramatically CHANGING the perception once the actual numbers and forecasts are out.

  • It's largely because the key Jewish gift-giving holiday of Hanukkah fell in NOVEMER this year whereas in most years including 2012, it fell in the month of December. Jews make up about 2% of the American population but they account for about 3% of the spending.

    In my opinion, the reluctance of JCP to give specifics for the month of December means that they had a slight miss - perhaps 3% or 4%. I say SLIGHT miss because after all management did reiterate previously-given guidance for the November through January quarter and so if they beat by 4% or 5% in November, in order to simply meet guidance, they would have logically missed by perhaps 3% to 4% in the larger month of December assuming that January is about flat with estimates.

    Of the likely December miss, most of it is simply due to the different month that Hanukkah occurred this year. It's irrational to think that they were going great guns in October and November (including Black Friday and Cyber Monday) and then completely fell apart in December without there being logical reasons.

    JCP and other retailers got a tremendous lift in November in comparison with last year due to Hanukkah occurring in November this year but of course that hurt the DECEMBER comps this year when last year contained Hanukkah but this year didn#$%$ rather amazing that more analysts can't see this.

  • As long as this board is dominated with political junk, don't expect to see me post very much. Long-term readers may remember that even though I got heavily involved in Pfizer on Nov. 17, 2004, it wasn't until early 2007 that I started posting on this board since prior to that, a party calling himself "Mexie" dominated things with hateful posts and political nonsense.

    I'll check back from time to time to see if things have gotten back to normal but as long as the board continues to look like it does not, there just won't be much participation from me.

    I don't really have a lot of spare time for posting these days as my investing consulting business has really taken off and I'm devoting oodles of time to it.

    Happy New Year and good luck to the few remaining good people on this board. As for the rest of you, I'll sign off by re-posting a previous comment of mine that some people have my back while a lot more have my right middle finger.

  • fizrwinnr11 fizrwinnr11 Jan 13, 2014 2:48 AM Flag

    Pfizer has drastically underperformed the market since I unloaded it at $29.21 the first week of April. I invested 300K of the proceeds in BIDU and that investment is currently up by over EIGHTY percent. I'm pretty much maxed out on that investment now but I need to hold it until the end of the first quarter in order to establish a long-term capital gain.

    Pfizer last year ranked only #19 on the Dow and #7 on the list of the ten large domestic and foreign pharmas that I follow.

  • Cities visited will be Tokyo, Singapore, Bangkok, Ho Chi Minh City, Da Nang, Hanoi, Hong Kong and Macau. I will return on Tuesday, Feb. 18.

  • 2013: #19
    2012: #08
    2011: #03
    2010: #24

  • 12/31/12 - 951,950 (S & P 1,426) Balance at beginning of 2013

    01/02 - 1,000,725 (S & P 1,462) - 2013 valuation low to date
    01/29 - 1,067,885 (S & P 1,508)
    02/08 - 1,050,545 (S & P 1,518)
    02/19 - 1,072,805 (S & P 1,531)
    02/25 - 1,050,295 (S & P 1,488)
    04/02 - 1,114,865 (S & P 1,570) - Final PFE cash-out for 796K with stock at $29.21
    04/05 - 1,082,205 (S & P 1,553)
    04/12 - 1,131,750 (S & P 1,589)
    04/18 - 1,096,390 (S & P 1,542)
    05/21 - 1,231,335 (S & P 1,669)
    05/23 - 1,197,840 (S & P 1,651)
    05/30 - 1,231,575 (S & P 1,654)
    06/05 - 1,193,895 (S & P 1,609)
    06/10 - 1,257,840 (S & P 1,643)
    06/24 - 1,079,495 (S & P 1,573)
    06/28 - 1,166,770 (S & P 1,606)
    07/03 - 1,124,200 (S & P 1,615)
    07/30 - 1,331,800 (S & P 1,686)
    08/09 - 1,257,130 (S & P 1,691)
    09/19 - 1,375,040 (S & P 1,722)
    10/21 - 1,118,865 (S & P 1,745)
    11/01 - 1,262,265 (S & P 1,762)
    11/06 - 1,214,660 (S & P 1,770)
    11/29 - 1,466,310 (S & P 1,806)
    12/06 - 1,344,860 (S & P 1,805)
    12/27 - 1,467,900 (S & P 1,841)
    12/31 - 1,477,970 (S & P 1,848) - 2013 valuation high

    Up 55.3%. Combined portfolio gains
    Up 29.6%. S & P 500

    Note: This is be the third consecutive year where my combined portfolio performance is 40% or more. In 2011 in a flat overall market, I achieved a startling 58% overall return and I followed that up last year with 42% combined gains. For 2013, I once again wind up in the 50's - this time at 55%.. To the utter dismay of my many detractors, my Eureka moment in mid-August of 2011 has turned me into the very best percentage wealth creator in the land. Nobody matches my performance over time in non-crashing markets factoring in the low risk that I have.

    In the Dec. 6 edition of Money Magazine, the top stock funds since the end of 2010 were shown. There were only a handful of funds that achieved 30% or greater average annualized returns with the top one being 40.6%. Yours truly just wound up achieving an amazing 52% annualized since then.

  • 11/04 - transfer in 140,000 from the quarter-million-dollar long-term naked put-writing portfolio. JCP at $8.15, S & P at 1,762

    11/06 - 127,485 ($7.70) (S & P 1,770), low valuation from inception
    11/29 - 168,090 (10.05) (S & P 1,806)
    12/06 - 157,355 ($8.08) (S & P 1,805)
    12/27 - 174,610 ($9.01) (S & P 1,841)
    12/31 - 177,245 ($9.15) (S & P 1,848), high valuation from inception

    Up 26.6%. Portfolio gain to date (average of 3.1% per week)
    Up 12.3%. Stock price gain from inception

    Up 04.8%. S & P 500 (1,762 to 1,848)

    Current Positions:

    275 contracts of the Jan..5-strikes (paper profits of $4,815), $550 remaining to expiry
    280 contracts of the Jan. 4-strikes (paper profits of $3,380), $280 remaining to expiry
    100 contracts of the Feb. 5-strikes (paper profits of $2,680), $1,000 remaining to expiry
    200 contracts of the Feb. 4-strikes (paper profits of $3,170), $1,000 remaining to expiry
    800 contracts of the Mar. 5-strikes (paper profits of $5,790), $14,400 remaining to expiry
    400 contracts of the Mar. 4-strikes (paper profits of $8,185), $4,400 remaining to expiry

    Closed-Out Positions:

    1) $935 profits on a $7,000 investment in 100 of the 6-strikes for Nov. 22
    2) 1,950 profits on a $9,600 investment in 150 of the 5.50-strikes for Nov. 29
    3) 1,880 profits on an $8,650 investment in 100 of the 6.50-strikes for Dec. 13
    4) 4,460 profits on a $25,320 investment in 400 of the 5-strikes for December

  • fizrwinnr11 fizrwinnr11 Jan 5, 2014 7:41 PM Flag

    Current positions:

    1) 500 contracts of the JCP Jan. 08-strikes (stock at $9.15). Paper gains of $7,680.
    2) 200 contracts of the JCP Jan. 10-strikes (stock at $9.15). Paper LOSSES of $11,930.
    3) 100 contracts of the HPQ Feb 16-strikes (stock at $28.02).Paper gains of $4,030.
    4) 300 contracts of the JCP Feb. 06-strikes (stock at $9.15). Paper gains of $3,685.
    5) 300 contracts of the JCP Mar. 06-strikes (stock at $9.15). Paper LOSSES of $3,600
    6) 200 contracts of the JCP Mar. 05 strikes (stock at $9.15). Paper gains of $4,005


    Closed-out positions:

    1) $2,005 profits in four weeks on a $17,550 investment in the JCP May 10-strikes
    2) $1,355 profits in six weeks on a $16,600 investment in the KORS Aug. 36-strikes
    3) $2,460 profits in five weeks on a $14,605 investment in the JCP July 10-strikes
    4) $9,390 profits in sixteen weeks on a $40,500 investment in the JCP Aug. 10-strikes
    5) $7,740 profits in seventeen weeks on a $27,400 investment in the KORS Jan. 45-strikes
    6) $6,450 profits in sixteen weeks on a $36,500 investment in the AIG Jan. 35-strikes
    7) $3,455 profits in three weeks on a $14,800 investment in the JCP 5.50-strikes for Nov. 22

  • 04/03 - initiation of the 200K portfolio with the S & P at 1,570

    04/09 - 197,945 (S & P 1,569)
    06/10 - 222,315 (S & P 1,643)
    06/24 - 202,375 (S & P 1,573)
    07/23 - 235,015 (S & P 1,692), high valuation from inception
    08/09 - 177,015 (S & P 1.691)
    08/15- 201,485 (S & P 1,661)
    08/19 - 190,115 (S & P 1,646)
    09/17 - 234,850 (S & P 1,705)
    09/24 - 209,950 (S & P 1,697), just prior to release of Goldman Sachs report
    09/25 - 152,150 (S & P 1,693) devastating Goldman Report on JCP
    09/27 - 120,850 (S & P 1,692), company forced to issue 38% more stock
    10/04 - 074,710 (S & P 1,691), false Twitter rumors about company meeting with bankruptcy attorneys
    10/15 - 032,465 (S & P 1,698), false Twitter rumors about shut-off of vendor financing from Canadian factor
    10/21 -(023,135)(S & P 1,745), low valuation from inception, small brokerage sets $1 target price
    10/29 - 040,475 (S & P 1,772), management reiterates Q4 revenue growth forecast
    11/01 - 107,835 (S & P 1,762), upgrade by a small brokerage
    11/04 - 127,255 (S & P 1,768)
    11/06 - 084,380 (S & P 1,770), Nielsen survey shows fewer than expected shoppers on Black Friday
    11/07 - 115,745 (S & P 1,747), positive same-store comparisons for month of October
    11/20 - 196,310 (S & P 1,781), Q3 revenues meet expectations, upbeat conference call
    11/22 - 189,410 (S & P 1,805), JCP to be removed from S & P 500 index after 11/29 close
    11/29 - 232,950 (S & P 1,806)
    12/06 - 157,210 (S & P 1,805), 10-Q indicates that SEC is investigating late Sept. stock sale
    12/13 - 188,310 (S & P 1,775)
    12/19 - 165,510 (S & P 1,809)
    12/27 - 228,210 (S & P 1,841)
    12/31 - 236,725 (S & P 1,848)

    Up 17.7%. Portfolio gain to date
    Up 17.7%. S & P 500

    Current positions:
    1) 500 contracts of the JCP Jan. 08-strikes (stock at $9.15). Paper gains of $7,680.
    2) 200 contracts of the JCP Jan. 10-strikes (stock at $9.15). Paper LOSSES of $11,930.
    3) 100 contracts of the HPQ Feb 16-strikes (stock at $27.98).Paper gains of $4,030.
    4) 300 contracts of the JCP Feb. 06-strikes (s

  • 12/31/12 - 250,000 - (S & P 1,426) Beginning balance for the new year

    01/02 - 262,500 - (S & P 1,462), low valuation of 2013
    01/29 - 291,770 - (S & P 1,508)
    02/07 - 282,320 - (S & P 1,509)
    02/19 - 292,080 - (S & P 1,531)
    03/04 - 277,090 - (S & P 1,525)
    04/11 - 301,160 - (S & P 1,593)
    04/18 - 285,690 - (S & P 1,542)
    05/08 - 326,675 - (S & P 1,633)
    06/24 - 268,615 - (S & P 1,573)
    07/23 - 308,890 - (S & P 1,692)
    08/07 - 290,700 - (S & P 1,691)
    09/18 - 329,185 - (S & P 1,726), high valuation of 2013 to date
    10/15 - 287,795 - (S & P 1,698)
    11/01 - 307,450 - (S & P 1,762)

    11/04/13 - transfer 140K to the new JCP short-term naked put-writing portfolio)

    11/04 - 171,840 - (S & P 1,768)
    11/06 - 168,440 - (S & P 1,770)
    11/29 - 185,240 - (S & P 1,806)
    12/06 - 159,215 - (S & P 1,805)
    12/20 - 166,845 - (S & P 1,818)
    12/27 - 177,885 - (S & P 1,841)
    12/31 - 178,740 - (S & P 1,848)

    Up 30.1% - 2013 portfolio gains to date (based on average invested capital of $227,400)
    Up 29.6% - 2013 S & P gains to date

    Current holdings:

    JCP 8-strikes for Jan. 2014 (100 contracts with stock at $9.15)
    JCP 5-strikes for Jan. 2015 (200 contracts with stock at $9.15)
    QCOM 45-strikes for Jan. 2015 (25 contracts with stock at $74.25)
    GG 23-strikes for Jan. 2015 (50 contracts with stock at $21.67)
    AGNC 20-strikes for Jan. 2015 (50 contracts with stock at $19.29)
    KORS 45-strikes for Jan. 2015 (30 contracts with stock at $81.19)
    AIG 37-strikes for Jan. 2015 (30 contracts with stock at $51.05)
    PBR 13-strikes for Jan. 2015 (60 contracts with stock at $13.18)

  • 05/14 - initiation of the 295K portfolio with the S & P at 1,634

    05/30 - 300,730 (S & P 1,654)
    06/24 - 255,050 (S & P 1,573), low valuation from inception
    09/19 - 343,005 (S & P 1,722)
    10/08 - 316,210 (S & P 1,676)
    10/28 - 360,835 (S & P 1,762), high valuation from inception
    12/13 - 347,560 (S & P 1,775)
    12/20 - 349,275 (S & P 1,818)
    12/27 - 355,350 (S & P 1,841)
    12/31 - 356,380 (S & P 1,848)

    Up 20.8%. Portfolio gains to date
    Up 13.1%. S & P 500

    Current positions:

    1) long 230 INTC Jan. 20's, short Jan. 23's (stock at $25.76)(paper profit of $10,200)
    2) long 120 F 10's, short 15's for Jan. 2015 (stock at $15.24)(paper profit of $1,630)
    3) long 040 BIDU 90's, short 110's for Jan. 2015 (stock at $177.88)(paper profit of $9,825)
    4) long 050 CAT 65's, short 75's for Jan. 2015 (stock at $90.81)(paper profit of $5,725)

    Closed-out positions:

    1) $4,000 profit in two months on a KORS Jan. 40/45 spread on an investment of $42,530
    2) $5,715 profit in 2.2 months on an AIG Jan. 33/38 spread on an investment of $40,660
    3) 25,225 profit in four months on a BIDU Jan. 70/80 spread on an investment of $72,050
    4) $6,220 profit in 3.8 months on an EWY Jan. 45/50 spread on an investment of $42,110
    5) $6,650 LOSS in 7.4 months on a GG Jan. 18/23 spread on an investment of $40,620

  • 03/25 - transfer in 300,000 from the Pfizer portfolio. BIDU stock is at $84.85, S & P 500 is 1,557

    03/25 - 302,740 - ($85.33) RSI 35.0
    04/02 - 323,085 - ($88.12) RSI 46.6
    04/05 - 293,125 - ($83.59) RSI 34.8, lowest stock close and valuation from inception
    04/12 - 337,805 - ($90.62) RSI 56.9
    04/22 - 306,925 - ($85.66) RSI 42.2
    04/25 - 349,725 - ($92.34) RSI 60.2
    04/26 - 305,205 - ($85.02) RSI 44.2, Q1-13 earnings and 2013 outlook disappoint
    05/03 - 300,285 - ($84.51) RSI 43.5
    06/10 - 428,205 - (102.99) RSI 66.9
    06/24 - 352,765 - ($89.89) RSI 37.8
    06/28 - 382,900 - ($94.60) RSI 49.3
    07/03 - 351,125 - ($89.22) RSI 38.5
    07/24 - 453,520 - (113.37) RSI 75.2, session prior to release of Q2-13 earnings
    07/25 - 460,575 - (125.85) RSI 83.5, Q2-13 earnings released, outlook for year raised
    08/02 - 459,585 - (139.70) RSI 89.0, one of the highest RSI readings seen in any stock
    08/13 - 475,155 - (141.53) RSI 78.7
    09/05 - 438,150 - (132.99) RSI 51.3
    09/11 - 473,925 - (147.31) RSI 70.0
    09/13 - 459,120 - (142.64) RSI 60.9
    10/30 - 503.335 - (164.93) RSI 60.4
    11/07 - 482,090 - (147.35) RSI 42.2
    12/10 - 537,930 - (179.93) RSI 73.4, highest stock close and valuation from inception
    12/13 - 524,170 - (171.24) RSI 58.9
    12/27 - 530,605 - (173.77) RSI 58.6
    12/31 - 529,105 - (177.88) RSI 63.3


    Up 076.4%. Portfolio gain to date
    Up 110.7%. BIDU stock from inception

    Up 018.7%. S & P 500 from inception of investment (1,557 to 1,848)


    Note: While I am nearly maxed out on this investment, I will continue to hold until late March in order to establish a long-term capital gain.

  • Sold 100 GG Jan. 18-strike calls and bought back 100 Jan. 23-strikes for a net of $3.41 per unit or $33,970 after commissions. The spread had been sold for $405 per unit or $40,620 on May 16. Losses for the 7.5-month holding period amounted to $6,650. The nominal percentage loss was 16.4% on a stock price drop from $29.36 to $21.74 or 26.3%.

    The investment wqs done in an IRA account where naked put selling is not allowed. Had it been an unrestricted account, I would have sold something like 18 or 20-strike naked puts and despite the considerable stock price drop, I would have ended up with some nice profits.

    12/31/2013 13:27:46 Sold 100 GG Jan 18 2014 18.0 Call @ 3.65 36,434.96
    12/31/2013 13:30:34 Bought 100 GG Jan 18 2014 23.0 Call @ 0.24 -2,464.40

  • 1) Bought back 60 PBR Jan. 15-strike naked puts for $136 apiece or $8,200 after commissions. The options had originally been sold for $169 each back on May 4, 2012 when the stock was trading at $20.25. So even though the stock tanked from $20.25 to $13.74 during the nearly 20-month holding period, I actually wound up with net PROFITS after commissions of $1,900 on a $20.940 investment. A 9% return in 20 months is of course no great shakes but how many others do that on a bullish investment in an underlying stock that loses almost a third of its value? It's this sort of thing that allows me to have the overall returns that I have.

    2) Sold 60 PBR 13-strike naked puts expiring in Jan. 2015 for about $158 apiece. Net proceeds of $9,440 after commissions on an investment of $21,490.

    12/30/2013 10:59:22 Bought 60 PBR Jan 18 2014 15.0 Put @ 1.36 -8,201.44
    12/30/2013 11:08:13 Sold 1 PBR Jan 17 2015 13.0 Put @ 1.6 159.41
    12/30/2013 11:08:13 Sold 59 PBR Jan 17 2015 13.0 Put @ 1.58 9,280.96

  • Sold 300 JCP Mar 5-strike naked puts for an averabe of $17.10 apiece. Net proceeds of $4,930 after commissions on net cash margin requirements of $20,700. If the stock remains above $5 for the 12-week holding periiod, the return will be 1.98% per week.

    12/30/2013 14:47:38 Sold 20 JCP Mar 22 2014 5.0 Put @ 0.18 348.51
    12/30/2013 14:47:38 Sold 12 JCP Mar 22 2014 5.0 Put @ 0.18 202.10
    12/30/2013 14:47:42 Sold 58 JCP Mar 22 2014 5.0 Put @ 0.17 952.68
    12/30/2013 14:48:55 Sold 90 JCP Mar 22 2014 5.0 Put @ 0.17 1,471.31
    12/30/2013 14:50:35 Sold 90 JCP Mar 22 2014 5.0 Put @ 0.17 1,471.31
    12/30/2013 14:51:54 Sold 11 JCP Mar 22 2014 5.0 Put @ 0.17 180.67
    12/30/2013 14:51:54 Sold 10 JCP Mar 22 2014 5.0 Put @ 0.17 164.25
    12/30/2013 14:51:54 Sold 9 JCP Mar 22 2014 5.0 Put @ 0.17 147.43

  • 11/04 - transfer in 140,000 from the quarter-million-dollar long-term naked put-writing portfolio. JCP at $8.15, S & P at 1,762

    11/06 - 127,485 ($7.70) (S & P 1,770), low valuation from inception
    11/29 - 168,090 (10.05) (S & P 1,806)
    12/06 - 157,355 ($8.08) (S & P 1,805)
    12/20 - 168,005 ($8.32) (S & P 1,818)
    12/27 - 174,610 ($9.01) (S & P 1,841), high valuation from inception

    Up 24.7%. Portfolio gain to date (average of 3.1% per week)
    Up 10.5%. Stock price gain from inception

    Up 05.0%. S & P 500 (1,762 to 1,841)

    Current Positions:

    275 contracts of the Jan..5-strikes (paper profits of $4,540), $825 remaining to expiry
    280 contracts of the Jan. 4-strikes (paper profits of $2,820), $840 remaining to expiry
    100 contracts of the Feb. 5-strikes (paper profits of $2,580), $1,100 remaining to expiry
    200 contracts of the Feb. 4-strikes (paper profits of $2,970), $400 remaining to expiry
    800 contracts of the Mar. 5-strikes (paper profits of $4,190), $16,000 remaining to expiry
    400 contracts of the Mar. 4-strikes (paper profits of $8,185), $4,400 remaining to expiry

    Closed-Out Positions:

    1) $935 profits on a $7,000 investment in 100 of the 6-strikes for Nov. 22
    2) 1,950 profits on a $9,600 investment in 150 of the 5.50-strikes for Nov. 29
    3) 1,880 profits on an $8,650 investment in 100 of the 6.50-strikes for Dec. 13
    4) 4,460 profits on a $25,320 investment in 400 of the 5-strikes for December

  • fizrwinnr11 fizrwinnr11 Dec 30, 2013 12:36 AM Flag

    Current positions:

    1) 500 contracts of the JCP Jan. 08-strikes (stock at $9.01). Paper gains of $5,180.
    2) 200 contracts of the JCP Jan. 10-strikes (stock at $9.01). Paper LOSSES of $16,130.
    3) 100 contracts of the HPQ Feb 16-strikes (stock at $28.19).Paper gains of $4,030.
    4) 300 contracts of the JCP Feb. 06-strikes (stock at $9.01). Paper gains of $2,785.
    5) 300 contracts of the JCP Mar. 06-strikes (stock at $9.01). Paper losses of $8,015
    6) 200 contracts of the JCP Mar. 05 strikes (stock at $9.01). Paper gains of $3,605


    Closed-out positions:

    1) $2,005 profits in four weeks on a $17,550 investment in the JCP May 10-strikes
    2) $1,355 profits in six weeks on a $16,600 investment in the KORS Aug. 36-strikes
    3) $2,460 profits in five weeks on a $14,605 investment in the JCP July 10-strikes
    4) $9,390 profits in sixteen weeks on a $40,500 investment in the JCP Aug. 10-strikes
    5) $7,740 profits in seventeen weeks on a $27,400 investment in the KORS Jan. 45-strikes
    6) $6,450 profits in sixteen weeks on a $36,500 investment in the AIG Jan. 35-strikes
    7) $3,455 profits in three weeks on a $14,800 investment in the JCP 5.50-strikes for Nov. 22

  • 04/03 - initiation of the 200K portfolio with the S & P at 1,570

    04/09 - 197,945 (S & P 1,569)
    06/10 - 222,315 (S & P 1,643)
    06/24 - 202,375 (S & P 1,573)
    07/23 - 235,015 (S & P 1,692), high valuation from inception
    08/09 - 177,015 (S & P 1.691)
    08/15- 201,485 (S & P 1,661)
    08/19 - 190,115 (S & P 1,646)
    09/17 - 234,850 (S & P 1,705)
    09/24 - 209,950 (S & P 1,697), just prior to release of Goldman Sachs report
    09/25 - 152,150 (S & P 1,693) devastating Goldman Report on JCP
    09/27 - 120,850 (S & P 1,692), company forced to issue 38% more stock
    10/04 - 074,710 (S & P 1,691), false Twitter rumors about company meeting with bankruptcy attorneys
    10/15 - 032,465 (S & P 1,698), false Twitter rumors about shut-off of vendor financing from Canadian factor
    10/21 -(023,135)(S & P 1,745), low valuation from inception, small brokerage sets $1 target price
    10/29 - 040,475 (S & P 1,772), management reiterates Q4 revenue growth forecast
    11/01 - 107,835 (S & P 1,762), upgrade by a small brokerage
    11/04 - 127,255 (S & P 1,768)
    11/06 - 084,380 (S & P 1,770), Nielsen survey shows fewer than expected shoppers on Black Friday
    11/07 - 115,745 (S & P 1,747), positive same-store comparisons for month of October
    11/20 - 196,310 (S & P 1,781), Q3 revenues meet expectations, upbeat conference call
    11/22 - 189,410 (S & P 1,805), JCP to be removed from S & P 500 index after 11/29 close
    11/29 - 232,950 (S & P 1,806)
    12/06 - 157,210 (S & P 1,805), 10-Q indicates that SEC is investigating late Sept. stock sale
    12/13 - 188,310 (S & P 1,775)
    12/19 - 165,510 (S & P 1,809)
    12/20 - 190,510 (S & P 1,818)
    12/27 - 228,210 (S & P 1,841)

    Up 14.1%. Portfolio gain to date
    Up 17.3%. S & P 500

    Current positions:
    1) 500 contracts of the JCP Jan. 08-strikes (stock at $9.01). Paper gains of $5,180.
    2) 200 contracts of the JCP Jan. 10-strikes (stock at $9.01). Paper LOSSES of $16,130.
    3) 100 contracts of the HPQ Feb 16-strikes (stock at $28.19).Paper gains of $4,030.
    4) 300 contracts of the JCP Feb. 06-strikes (s

PFE
30.07+0.07(+0.23%)Jul 11 4:01 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.